about
Partial unilateral lentiginosis treated with alexandrite Q-switched laser: case report and review of the literature.Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-Weber syndrome: phase II, randomized, double-blind, intraindividual placebo-controlled clinical trial.Diagnosis and management of extensive vascular malformations of the lower limb: part I. Clinical diagnosis.Photodynamic therapy for actinic keratosis in organ transplant patients.Methyl-ALA-induced fluorescence in photodynamic diagnosis of basal cell carcinoma prior to Mohs micrographic surgery.Angiogenic and prothrombotic markers in extensive slow-flow vascular malformations: implications for antiangiogenic/antithrombotic strategies.Foot or hand malformations related to deep venous system anomalies of the lower limb in Klippel-Trénaunay syndrome.[Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].[Repigmentation of gray hair after thyroid hormone treatment]Efficacy of Autologous Melanocyte Transplantation on Amniotic Membrane in Patients With Stable Leukoderma: A Randomized Clinical Trial.Lesions of pemphigus vulgaris on irradiated skin.Reply to: "Topical rapamycin combined with pulsed dye laser (PDL) in the treatment of capillary vascular malformations-Anatomical differences in response to PDL are relevant to interpretation of study results".A new KRT16 mutation associated with a phenotype of pachyonychia congenita.Acute Generalized Exanthematous Pustulosis Induced by SorafenibErythema gyratum repens-like eruption in a patient with epidermolysis bullosa acquisita associated with ulcerative colitisA novel missense mutation in the CYLD gene in a Spanish family with multiple familial trichoepitheliomaPulmonary arterial hypertension in patients with slow-flow vascular malformationsDermoscopic "setting sun" pattern of juvenile xanthogranuloma
P50
Q34577545-B5B9F9E3-98F4-44A4-B169-AEE77488216EQ35470985-7A01FA96-8624-4057-9B37-18E7CB08A8DAQ37946017-A0B80CF1-B58C-427E-9E2D-16F4B687D119Q37965984-7ADB372B-0546-4D68-B9BC-475E5BF89FE6Q42523859-A3B9E0B9-6BFD-4EA5-9B67-8ECAEA56A403Q43273531-7C7A6AA3-0CCD-42FE-906B-F115A76135ACQ43445165-154C01D5-A9AC-4396-8AC3-D01207B91ED8Q46009977-18EFEB0D-A623-4AE2-B2C4-F4AF20FC5641Q46931240-C7325166-01D6-4A2B-9983-2075EC167F91Q48040202-1CE17242-B9FD-46C0-9E3A-F8BA9DDC0B92Q51838239-BD583917-C688-4FCC-9B0D-230CC4812C57Q53180955-DBB7C0F1-E7F4-42F1-A804-DFD713CAF5EDQ54775852-244B9FAC-338B-4134-A562-209DAD467F19Q59463897-0BA19EF3-B336-4996-B70D-90D30AEF5F1FQ79690495-1DDB24AB-0606-4D0F-AA93-D5B580F2983EQ81310670-0DABA227-E09F-42A1-BBDF-17D5AF42C4B2Q82969603-71FA13AF-0A35-404F-9FB7-012AF0659828Q86261214-DA4C1BF5-2FA4-4230-83EB-B28C47BFE83D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Leyre Aguado
@ast
Leyre Aguado
@en
Leyre Aguado
@es
Leyre Aguado
@nl
Leyre Aguado
@sl
type
label
Leyre Aguado
@ast
Leyre Aguado
@en
Leyre Aguado
@es
Leyre Aguado
@nl
Leyre Aguado
@sl
altLabel
L Aguado Gil
@en
L Aguado
@en
prefLabel
Leyre Aguado
@ast
Leyre Aguado
@en
Leyre Aguado
@es
Leyre Aguado
@nl
Leyre Aguado
@sl
P1053
H-6838-2017
P106
P1153
23476782500
P31
P3829
P496
0000-0001-7445-3211